BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37491944)

  • 21. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction.
    Kusuyama J; Seong C; Nakamura T; Ohnishi T; Amir MS; Shima K; Semba I; Noguchi K; Matsuguchi T
    Int J Biochem Cell Biol; 2019 Nov; 116():105614. PubMed ID: 31550547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.
    Zhang L; Hou X; Lu S; Rao H; Hou J; Luo R; Huang H; Zhao H; Jian H; Chen Z; Liao M; Wang X
    Lung Cancer; 2010 Jan; 67(1):114-9. PubMed ID: 19376608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.
    Chang YS; Kim HJ; Chang J; Ahn CM; Kim SK; Kim SK
    Lung Cancer; 2007 Sep; 57(3):373-80. PubMed ID: 17513004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection.
    Yan CH; Lv M; Li H; Song X; Yan F; Cao S; Ren X
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1371-8. PubMed ID: 25555465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
    Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
    Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR4 Accelerates Osteoclastogenesis Induced by Non-Small Cell Lung Carcinoma Cells Through Self-Potentiation and VCAM1 Secretion.
    Liao T; Chen W; Sun J; Zhang Y; Hu X; Yang S; Qiu H; Li S; Chu T
    Cell Physiol Biochem; 2018; 50(3):1084-1099. PubMed ID: 30355915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OPN N-glycosylation promoted bone destruction.
    Dong M; Sun Q; Yu X; Sui L; Xu Y; Kong H; Kong Y
    Oral Dis; 2023 Jul; 29(5):2154-2162. PubMed ID: 35451542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteopontin is associated with decreased apoptosis and αv integrin expression in lung adenocarcinoma.
    Štemberger C; Matušan-Ilijaš K; Avirović M; Bulat-Kardum L; Ivančić A; Jonjić N; Lučin K
    Acta Histochem; 2014 Jan; 116(1):222-9. PubMed ID: 23992637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C.
    Liao M; Peng L
    Cell Mol Biol Lett; 2020; 25():22. PubMed ID: 32206066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
    Huang H; Huang J; Yao J; Li N; Yang Z
    J Cell Biochem; 2020 Jun; 121(5-6):3197-3207. PubMed ID: 31930562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
    Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
    J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?
    Ayan AK; Erdemci B; Orsal E; Bayraktutan Z; Akpinar E; Topcu A; Turkeli M; Seven B
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):102-6. PubMed ID: 26521996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of FGF-2 and osteopontin in non-small cell lung cancer].
    Li T; Zhou J; Deng Z; Fu C; Jiang H; Gao Z; Wang J; Ren H; Wang P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1114-9. PubMed ID: 19952401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.
    Kwak TK; Sohn EJ; Kim S; Won G; Choi JU; Jeong K; Jeong M; Kwon OS; Kim SH
    BMC Complement Altern Med; 2014 Oct; 14():419. PubMed ID: 25345853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
    Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
    Kang CG; Lee HJ; Kim SH; Lee EO
    J Nat Prod; 2016 Jan; 79(1):156-60. PubMed ID: 26681550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1.
    Huang W; Yan Y; Liu Y; Lin M; Ma J; Zhang W; Dai J; Li J; Guo Q; Chen H; Makabel B; Liu H; Su C; Bi H; Zhang J
    Signal Transduct Target Ther; 2020 Apr; 5(1):39. PubMed ID: 32317629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.